Abstract:Anxiety continues to represent a major unmet medical need. Despite the availability of numerous anxiolytic drugs, a large proportion of patients do not respond well to current pharmacotherapy, or their response diminishes with chronic drug application. To discover novel compounds and to investigate the mode of action of anxiolytic drugs, animal models have been proposed. The zebrafish is a novel animal model in this research. It is particularly appropriate, as it has evolutionarily conserved features, and drug administration can be employed in a non-invasive manner by immersing the fish into the drug solution. The first step in the analysis of anxiolytic drugs with zebrafish is to test reference compounds. Here, we investigate the effects of buspirone hydrochloride, an anxiolytic drug often employed in the human clinic. We utilize two genetically distinct populations of zebrafish, ABSK, derived from the quasi-inbred AB strain, and WT, a genetically heterogeneous wild-type population. We placed juvenile (10–13-day, post-fertilization, old) zebrafish singly in petri dishes containing one of four buspirone concentrations (0 mg/L control, 5 mg/L, 20 mg/L or 80 mg/L) for 1 h, with each fish receiving a single exposure to one concentration, a between subject experimental design. Subsequently, we recorded the behavior of the zebrafish for 30 min using video-tracking. Buspirone decreased distance moved, number of immobility episodes and thigmotaxis, and it increased immobility duration and turn angle in a quasi-linear dose dependent but genotype independent manner. Although it is unclear whether these changes represent anxiolysis in zebrafish, the results demonstrate that behavioral analysis of juvenile zebrafish may be a sensitive and simple way to quantify the effects of human anxiolytic drugs.

Zebrafish, a biological model for pharmaceutical research for the management of anxiety

Zebrafish Case

Behavioral neuroscience in zebrafish: unravelling the complexity of brain-behavior relationships

Importance of Zebrafish as an Efficient Research Model for the Screening of Novel Therapeutics in Neurological Disorders

Anxiolytic-like effects of acute serotonin-releasing agents in zebrafish models of anxiety: experimental study and systematic review

Zebrafish Model in Drug Safety Assessment

Behavioral Effects of Buspirone in Juvenile Zebrafish of Two Different Genetic Backgrounds

An Evaluation of Zebrafish, an Emerging Model Analyzing the Effects of Toxicants on Cognitive and Neuromuscular Function

Animal models of human disease: zebrafish swim into view

A brief history of zebrafish research--toward biomedicine]

Zebrafish as an animal model for biomedical research

Zebrafish: An Emerging Model System for Human Disease and Drug Discovery

Zebrafish as tools for drug discovery

Zebrafish and Medaka: new model organisms for modern biomedical research

Understanding neurobehavioral effects of acute and chronic stress in zebrafish

Zebrafish As a Developmental Model Organism for Pediatric Research.

Zebrafish: An emerging model system to study liver diseases and related drug discovery

Deep learning dives: Predicting anxiety in zebrafish through novel tank assay analysis

Zebrafish as a model organism for neurodegenerative disease

Sex differences shape zebrafish performance in a battery of anxiety tests and in response to acute scopolamine treatment

Sex, drugs, and zebrafish: Acute exposure to anxiety-modulating compounds in a modified novel tank dive test